about
Enhanced immune stimulation by a therapeutic lymphoma tumor antigen vaccine produced in insect cells involves mannose receptor targeting to antigen presenting cellsVirus-like particle (VLP)-based vaccines for pandemic influenza: performance of a VLP vaccine during the 2009 influenza pandemicAdenovirus as a carrier for the development of influenza virus-free avian influenza vaccines.Swine-origin pandemic H1N1 influenza virus-like particles produced in insect cells induce hemagglutination inhibiting antibodies in BALB/c mice.Trichoplusia ni cells (High Five) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccinesRecombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferretsMulti-antigen avian influenza a (H7N9) virus-like particles: particulate characterizations and immunogenicity evaluation in murine and avian models.Targets for the induction of protective immunity against influenza a viruses.Production and immunogenicity of chimeric virus-like particles containing the spike glycoprotein of infectious bronchitis virus.Evaluation of the Virus Counter® for rapid baculovirus quantitation.Comparative glycomics analysis of influenza Hemagglutinin (H5N1) produced in vaccine relevant cell platforms.Bacterially produced recombinant influenza vaccines based on virus-like particles.Modifications of cysteine residues in the transmembrane and cytoplasmic domains of a recombinant hemagglutinin protein prevent cross-linked multimer formation and potency lossInfluenza virus-like particles as an antigen-carrier platform for the ESAT-6 epitope of Mycobacterium tuberculosisProduction of H5N1 Influenza Virus Matrix Protein 2 Ectodomain Protein Bodies in Tobacco Plants and in Insect Cells as a Candidate Universal Influenza Vaccine.MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells.A novel platform for virus-like particle-display of flaviviral envelope domain III: induction of Dengue and West Nile virus neutralizing antibodiesImmunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge.Tnao38, high five and Sf9--evaluation of host-virus interactions in three different insect cell lines: baculovirus production and recombinant protein expressionAdjuvant-free immunization with hemagglutinin-Fc fusion proteins as an approach to influenza vaccines.
P2860
Q24658494-C4A3E90F-9497-4BFD-8143-A0581A0FD875Q26860373-4BE9F4FF-8542-4730-9B6C-30833A19A962Q30375982-F129CFF4-E1CE-4522-AA80-9D56469474A2Q30383973-A6CE4B2C-92CF-4311-A184-370D17EBF61AQ30387030-3EB03175-1B10-48C2-A6ED-4CAD1EBA363DQ30392305-84126E30-3ED7-4FDD-A8BD-66CE9D6F9158Q30397144-3E7C9845-5B68-4D48-AAD8-106CAB36ACD6Q30408100-9819E7A7-E6DB-4D76-9594-89987897B764Q33865400-B5C832D5-50A3-4E40-9ED9-E2350041996DQ34444411-01962773-FAD5-418A-B555-06B050FBB39BQ34814833-99B93F1F-9CFF-493C-B1CC-9FC1E6743161Q35048127-747F7C2A-1E24-4788-9EB0-A570CE010602Q35061360-3D676943-BFEF-4A20-AC9D-C795AF37D10CQ35300720-FF5676FB-736C-4AFC-9DA7-0B0B549E1822Q36352851-1C0D1588-1F8A-404A-B2EC-87443F8630CCQ36747588-91803B80-D494-4111-98EC-5C0F303B8D5CQ36889041-8B36B28B-B184-4523-BACC-464AB8FEC766Q37455326-E485FE52-7D13-4B1B-956E-F7AA9E870C84Q38281624-3E764596-6A40-43FF-B77C-865AE5C4E3CFQ39614628-59CF2DF1-A3D1-48F0-9F0A-EBD24939B664
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Progress on baculovirus-derived influenza vaccines.
@ast
Progress on baculovirus-derived influenza vaccines.
@en
type
label
Progress on baculovirus-derived influenza vaccines.
@ast
Progress on baculovirus-derived influenza vaccines.
@en
prefLabel
Progress on baculovirus-derived influenza vaccines.
@ast
Progress on baculovirus-derived influenza vaccines.
@en
P1476
Progress on baculovirus-derived influenza vaccines
@en
P2093
Manon M J Cox
P577
2008-02-01T00:00:00Z